September 10-11, 2024 | Pennsylvania Convention Center, Philadelphia

Data. AI. Precision. Innovation. For Pharma, Healthcare & Partners

ENQUIRE TO Sponsor
or exhibit

download
prospectus

register now
tickets from $495

LEADING DIGITAL TRANSFORMATION EVENT FOR PRECISION MEDICINE ON THE EAST COAST

1,500+

Attendees

300+

Speakers

80+

Exhibitors

100+

Biotech Start-Ups

2

Days

What is BioTechX USA?

Conference

Covering diagnostics, precision medicine, and digital transformation in pharmaceutical development and healthcare

APPLY TO SPEAK

Exhibition

80+ leading solution providers to meet your needs across drug discovery, data management and artificial intelligence

ENQUIRE TO SPONSOR/EXHIBIT

Networking

Networking is at the heart of BioTechX. Our congress allows you to connect directly with thousands of pharma experts across 2 days of built-in 1-2-1 networking

GET YOUR TICKET NOW

America’s most exciting biotechnology congress, bridging the gap between pharma, academia and clinicians to foster meaningful collaborations

AI IN DRUG DISCOVERY AND DEVELOPMENT

Advances in AI for drug development

AI in clinical trials

Limitations of AI in drug development

Data expansion in AI

LLMs

Applications of LLMs in Drug Development

Clinical Research

Practical application of LLMs

Cost effective ways to enable AI

Language models in Pharma

PRECISION MEDICINE AND LIQUID BIOPSY

Manufacturing CAR T cells

Immuno-oncology

Multi-cancer early detection

Personalised medicine for drug safety

BIG DATA IN ONCOLOGY

Clinical biomarkers

Tumour microenvironment

Translational data sources

Analytical and regulatory challenges

Oncology drug development

DATA INTEGRATION + FAIR

Research and development

Language models

Silo busting

Pre and post acquisition

BIOINFORMATICS + INSILICO R&D

Clinical development

Data driven drug discovery

Global biologics informatics platforms

Multi omics

DIGITAL TRANSFORMATION

Digital health solutions

Applications in the life science industry

Drug development efficiency

Inclusive data management

REAL WORLD EVIDENCE

Real world data

Future applications

Leveraging AI for RWE

Real world evidence in the clinical setting

GENE THERAPY

Treating genetic disorders with therapy

CRISPR and gene editing

Ethical concerns and regulations

BIOMARKERS + COMPANION DIAGNOSTICS

Image based machine learning models

Single molecule detection

Digital biomarkers

Multi-cancer early detection

RARE DISEASE IN GENOMICS

In-vivo gene editing

Accelerating medicines for rare diseases

Neurodevelopmental disorders

Future of rare diseases

QUANTUM INTEGRATION

Quantum machine learning

Quantum research

Drug discovery and development

Get your ticket now

Our incredible speaker line-up for 2024 includes

Michael Beste
Executive Director, Quantitative Sciences and Innovation
Novartis, Biomedical Research

nuvan a dassanaike
SVP of Marketing and Digital Strategy
Accord Healthcare
Cristina Duran
Chief Digital Health Officer R&D Global
AstraZeneca

Anne Heatherington
Head, Data Sciences Institute and R&D Chief Data & Technology Officer
Takeda
Faisal Khan
Corporate Vice President AI and Analytics
Novo Nordisk

Leo Russo
Vice President and Head of Global Medical Epidemiolog
Pfizer
Sandor Szalma
Global Head, Genetics and Systems Biology
Takeda

Joseph Szustakowski
Vice President, Translational Bioinformatics
Bristol-Myers Squibb
Xiaoying Wu
VP, Data Science Solutions, Privacy & Ethics, R&D
Johnson & Johnson Innovation

Lee-anne Zinetti
Senior Director, Global Lead Precision Medicine
Novartis
Eric Adam
Global Head of Operations, Neuroscience and Rare Diseases
Hoffmann-La-Roche

Suzette Girgis
Vice President, Head of Global Clinical Pharmacology & Pharmacometrics
Jazz Pharmaceuticals
Youssef Idelcaid
Head of Data Science - Commercial, Medical & Government affairs (CMG)
Genentech

Thomas Prangenberg
Head of Product and Design
Boehringer Ingelheim
Heresh Rezavandi
Director - Head of External Innovation Partnering (Search & Evaluation)
Angelini Pharmaceuticals

Ravinder Singh
Director Endocrine Laboratoies
Mayo Clinic
Shahed Iqbal
Executive Director and Head, Molecular Epidemiology, Biomarker Sciences
GILEAD SCIENCES

Nindhana Paranthaman
Executive Medical Director
Exelixis
Alex Sverdlov
Senior Director of Biostatistics
Novartis

Zane Wilson
Executive Director, Asset Strategy Leader
Abbvie
Charlene Son Rigby
Chief Executive Officer Global Genes
Global Genes

Emmanouil Dermitzakis
Vice President and Head of Computational Biology
GSK
Sashka Dimitrievska
Senior Director, Therapeutic Area, Head Of Oncology And Immuno-Oncology Information Practice
AstraZeneca

Samir Hanash
Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer
MD Anderson Cancer Center
Ioannis Kagiampakis
Portfolio Data Science Lead
AstraZeneca

Felix Lee
US Digital Healthcare Medical Head
Sanofi
Solomon Makgoeng
Director, Department of Epidemiology
Pfizer

G Mike Makrigiorgos
Professor and Director of Medical Physics and Biophysics Division, Professor Radiation Oncology
Dana-Farber Cancer Institute
Steve Prewitt
Senior Vice President, Global Head, Digital Innovation
Sumitovant BioPharma

Dimitri Talantov
Head of Experimental Medicine, Infectious Diseases
Janssen R&D
Sunil Talathi
Global Head and Director, Data Engineering and Analytics - Data Science and Digital Innovation (DSDI)
Beigene

Shams Zaman
Senior Director, Global Biometrics & Data Sciences
Bristol-Myers Squibb
Mr Duncan Johnstone
Head of Data Analytics
GSK

Adrian Jonas
Chief Analyst for the North West Region
NHS England
Kristy Singletary
Director, L&D Strategy Lead, Enabling Functions
Pfizer